Lynne Parshall Buys Shares of Foghorn Therapeutics Inc. $FHTX
Key Points
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Lynne Parshall, insider at Foghorn Therapeutics Inc. ($FHTX), bought 28,000 shares at an average price of $4.08, for a total transaction of $114,240. The trade was disclosed in a Form 4 filing with the Securities and Exchange Commission.
Foghorn Therapeutics Inc. Stock Down 32.8%
Shares of Foghorn Therapeutics Inc. ($FHTX) traded around $4.03 on Friday, down 32.8% for the day.
Foghorn Therapeutics Inc. Earnings
Analysts Set New Price Targets
About Foghorn Therapeutics Inc.
Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of medicines targeting genetically determined dependencies within the chromatin regulatory system in the United States. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is developing therapies for mutant; non-small cell lung; endometrial, cervical, ovarian, and bladder cancer; and diffuse large B-cell lymphoma, as well as various acute myeloid leukemia and myelodysplastic syndrome. The company has collaboration agreement with Eli Lilly and Company for developing FHD-909, a selective ATPase inhibitor of BRM. The company was incorporated in 2015 and is headquartered in Watertown, Massachusetts.
Get Foghorn Therapeutics Inc. alerts
New 13F filings, insider trades, and analyst moves on $FHTX, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.